Real-World Approach for Molecular Analysis of Acquired EGFR Tyrosine Kinase Inhibitor Resistance Mechanisms in NSCLC

por Hondelink, Liesbeth M., Jebbink, Merel, von der Thüsen, Jan H., Cohen, Danielle, Dubbink, Hendrikus J., Paats, Marthe S., Dingemans, Anne-Marie C., de Langen, Adrianus J., Boelens, Mirjam C., Smit, Egbert F., Postmus, Pieter E., van Wezel, Tom, Monkhorst, Kim
Publicado 2021

Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response

por Dammeijer, Floris, De Gooijer, Cornedine J., van Gulijk, Mandy, Lukkes, Melanie, Klaase, Larissa, Lievense, Lysanne A., Waasdorp, Cynthia, Jebbink, Merel, Bootsma, Gerben P., Stigt, Jos A., Biesma, Bonne, Kaijen-Lambers, Margaretha E.H., Mankor, Joanne, Vroman, Heleen, Cornelissen, Robin, Baas, Paul, Van der Noort, Vincent, Burgers, Jacobus A., Aerts, Joachim G.
Publicado 2021

Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer

por Veerman, G.D. Marijn, Boosman, Rene J., Jebbink, Merel, Oomen-de Hoop, Esther, van der Wekken, Anthonie J., Bahce, Idris, Hendriks, Lizza E.L., Croes, Sander, Steendam, Christi M.J., de Jonge, Evert, Koolen, Stijn L.W., Steeghs, Neeltje, van Schaik, Ron H.N., Smit, Egbert F., Dingemans, Anne-Marie C., Huitema, Alwin D.R., Mathijssen, Ron H.J.
Publicado 2023